29 results on '"Yoh K"'
Search Results
2. Impact of EGFR mutation status in patients with completely resected lung adenocarcinoma treated with adjuvant platinum-based chemotherapy.
3. Survival improvement in patients (pts) with small cell lung cancer (SCLC): A historical comparison before and after amrubicin (AMR) approval in Japan.
4. Phase II study of nedaplatin and docetaxel in patients with advanced squamous cell lung cancer.
5. A phase II trial of zoledronic acid in combination with cisplatin and docetaxel in non-small cell lung cancer patients with bone metastases.
6. Analysis of disease recurrence in the central nervous system (CNS) in patients with non-small cell lung cancer (NSCLC) after responded to gefitinib.
7. Current trend in incidence of severe interstitial lung disease (ILD) due to gefitinib in Japan
8. Validation study of direct sequencing and PCR-invader for detecting EGFR mutations in non-small cell lung cancer (NSCLC)
9. Chemoradiation therapy in patients (pts) with small cell lung cancer (SCLC) with pericardial effusion but no distant metastasis
10. Interstitial lung disease associated with amrubicin in the treatment of patients with small cell lung cancer
11. Trends in chemotherapy for elderly patients with non-small cell lung cancer: The experience of one institution
12. Analysis of optimal timing of gefitinib in sensitive non-small cell lung cancer (NSCLC) patients: Should we use gefitinib as first-line chemotherapy?
13. Clinical significance of chemotherapy for small cell lung cancer (SCLC) with ECOG performance status (PS) 3–4
14. Clinical significance of ABC transporter and DNA excision repair protein expressions in small-cell lung cancer (SCLC) patients
15. Trends in metastatic sites and survival for patients (pts) with stage IV lung cancer
16. Clinical outcome of chemoradiotherapy in patients (pts) with limited-disease small-cell lung cancer (LD-SCLC) with ipsilateral pleural effusion
17. The effect of pain on survival in non-small cell lung cancer (NSCLC) patients with bone metastases receiving chemotherapy
18. Prognostic factors for response and survival of second-line chemotherapy in patients with relapsed small cell lung cancer (SCLC)
19. Clinical predictive factors for mutations in epidermal growth factor receptor (EGFR) exon 19 and 21 in Japanese patients with lung cancer
20. Mutational analysis of EGFR and KIT in thymic epithelial tumor
21. Trends in demographics and survival for patients (pts) with advanced non-small cell lung cancer (NSCLC)
22. A phase II trial of paclitaxel plus carboplatin in patients with non-small cell lung cancer previously treated with chemotherapy
23. Dose intensive chemotherapy for limited-stage (LS) small cell lung cancer (SCLC): A phase II study
24. A randomized trial of 6-minutes drip infusion versus 1-minute bolus injection of vinorelbine (VNR) for the control of drug induced-phlebitis
25. Association of multiple pulmonary metastases with response to gefitinib in patients with non-small cell lung cancer
26. Association of multiple pulmonary metastases with response to gefitinib in patients with non-small cell lung cancer
27. First-line single agent of gefitinib in patients (pts) with advanced non-small cell lung cancer (NSCLC): A phase II study
28. A randomized trial of 6-minutes drip infusion versus 1-minute bolus injection of vinorelbine (VNR) for the control of drug induced-phlebitis
29. First-line single agent of gefitinib in patients (pts) with advanced non-small cell lung cancer (NSCLC): A phase II study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.